A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure that valid generic drugs may enter the market.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senator for Minnesota. Democrat.
Last Updated: Feb 28, 2018
Length: 11 pages
Feb 28, 2018
115th Congress, 2017–2019
Died in a previous Congress
This bill was introduced on February 28, 2018, in a previous session of Congress, but was not enacted.
Feb 28, 2018
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 2476 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). S. 2476 — 115th Congress: Expanding Access to Low Cost Generic Drugs Act. Retrieved from https://www.govtrack.us/congress/bills/115/s2476
“S. 2476 — 115th Congress: Expanding Access to Low Cost Generic Drugs Act.” www.GovTrack.us. 2018. March 26, 2019 <https://www.govtrack.us/congress/bills/115/s2476>
Expanding Access to Low Cost Generic Drugs Act, S. 2476, 115th Cong. (2018).
|title=S. 2476 (115th)
|accessdate=March 26, 2019
|author=115th Congress (2018)
|date=February 28, 2018
|quote=Expanding Access to Low Cost Generic Drugs Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.